DEVELOPMENT OF NOVEM AMINOGLYCODSIDE AGENTS WITH ACTIVITY AGAINST MULTI-DRUG RESISTANT ACINETOBACTER BAUMANNII

$2,724,779FY2008Department of DefenseDOD

Achaogen, Inc., South San Francisco CA

Investigators